Clik here to view.
Orphan Drug Designation Granted for Epidiolex in Dravet syndrome by the FDA
Cannabidiol Seven Expanded Access INDs granted by FDA to U.S. physicians to treat with Epidiolex 125 children suffering from intractable epilepsy syndromes - LONDON, Nov. 15, 2013 GW Pharmaceuticals...
View ArticleClik here to view.
GW Pharmaceuticals obtains Swiss approval for Sativex » All About Drugs
GW Pharmaceuticals obtains Swiss approval for Sativex » All About DrugsFiled under: Uncategorized Tagged: Cannabidiol, Nabiximols, sativex. tetrahydrocannabinol
View ArticleClik here to view.
FDA grants orphan drug designation to Insys Therapeutics’ pharmaceutical...
Systematic (IUPAC) name 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol Clinical data Trade names Epidiolex AHFS/Drugs.com International Drug Names Legal status...
View ArticleClik here to view.
FDA GIVES INSYS PHARMACEUTICAL CANNABIDIOL ORPHAN STATUS
FDA Gives Insys Pharmaceutical Cannabidiol Orphan Status Insys Therapeutics Inc., a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery...
View ArticleClik here to view.
FDA approves first drug Epidiolex (cannabidiol) comprised of an active...
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol)...
View ArticleClik here to view.
Cannabidiol, カンナビジオール;
Cannabidiol カンナビジオール; Formula C21H30O2 CAS 13956-29-1 Mol weight 314.4617 FDA APPROVED, 2018/6/25, Epidiolex (Greenwich Biosciences) Efficacy Anticonvulsant, Antiepileptic, Cannabinoid receptor...
View Article
